WallStreetZenWallStreetZen

NASDAQ: SKYE
Skye Bioscience Inc Stock Ownership - Who owns Skye Bioscience?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Skye Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kaitlyn ArsenaultChief Financial Officer2024-11-1843,026$4.99
$214.70kSell
Punit DhillonChief Executive Officer2024-11-1882,546$4.99
$411.90kSell
Tuan Tu DiepChief Development Officer2024-11-1819,489$4.99
$97.25kSell
Paul A. GraysonDirector2024-11-1886,244$4.99
$430.36kSell
Kaitlyn ArsenaultChief Financial Officer2024-11-1843,206$4.99
$215.60kSell
Punit DhillonChief Executive Officer2024-11-15364$5.55
$2.02kSell
Kaitlyn ArsenaultChief Financial Officer2024-11-15190$5.55
$1.05kSell
Tuan Tu DiepChief Development Officer2024-11-1585$5.55
$471.75Sell
Kaitlyn ArsenaultChief Financial Officer2024-11-15190$5.55
$1.05kSell
Paul A. GraysonDirector2024-11-15307$5.55
$1.70kSell

1 of 3

SKYE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SKYE insiders and whales buy or sell their stock.

SKYE Shareholders

What type of owners hold Skye Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures III LLC1,620.45%501,925,802$720.26MInsider
Emerald Health Sciences Inc546.93%169,407,901$243.10MInsider
Andrew J. Schwab32.00%9,913,168$14.23MInsider
5am Partners VII LLC32.00%9,913,168$14.23MInsider
5am Venture Management LLC32.00%9,913,168$14.23MInstitution
Cosmas N. Lykos14.85%4,599,400$6.60MInsider
Reg Alexander Lapham12.23%3,787,500$5.44MInsider
Versant Venture Management LLC6.48%2,007,704$2.88MInstitution
Sphera Funds Management Ltd5.05%1,564,628$2.25MInstitution
Richard D. Squires4.84%1,500,000$2.15MInsider

1 of 3

SKYE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SKYE3.44%96.56%Net Selling
GANX7.14%4.69%Net Buying
ICCC13.42%21.29%Net Buying
CUE19.02%9.15%Net Buying
PDSB9.34%26.04%Net BuyingNet Buying
View Top Biotech Stocks

Skye Bioscience Stock Ownership FAQ

Who owns Skye Bioscience?

Skye Bioscience (NASDAQ: SKYE) is owned by 81.38% institutional shareholders, 2,286.71% Skye Bioscience insiders, and 0.00% retail investors. Versant Ventures III LLC is the largest individual Skye Bioscience shareholder, owning 501.93M shares representing 1,620.45% of the company. Versant Ventures III LLC's Skye Bioscience shares are currently valued at $788.02M.

If you're new to stock investing, here's how to buy Skye Bioscience stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.